A multicenter phase II study on the safety of rho-kinase inhibitor (ripasudil) with needling for the patients after trabeculectomy

A multicenter phase II study on the safety of rho-kinase inhibitor (ripasudil) with needling for the patients after trabeculectomy

Background: There is no established method of maintaining or reducing intra ocular pressure after the needling procedure for failing blebs post trabeculectomy. Regarding newer antihypertensive medications, ripasudil, which is a rho-associated protein kinase inhibitor ophthalmic solution, was able to...

Full description

Bibliographic Details
Main Authors: Yu Mizuno, Kaori Komatsu, Kana Tokumo, Naoki Okada, Hiromitsu Onoe, Hideaki Okumichi, Kazuyuki Hirooka, Yukiko Miura, Yoshiaki Kiuchi
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:Contemporary Clinical Trials Communications
Subjects:
Glaucoma
Trabeculectomy
Needling
A rho-associated protein kinase inhibitor
Ripasudil
Online Access:http://www.sciencedirect.com/science/article/pii/S2451865423001060

Internet

http://www.sciencedirect.com/science/article/pii/S2451865423001060

Similar Items